Back
Dynatrace Vs. Vaxcyte Industry Stock Comparison
Sell
40
DT
Dynatrace
Last Price:
$41.70
Seasonality Move:
23.34%
Sell
10
PCVX
Vaxcyte
Last Price:
$32.50
Seasonality Move:
12.17%
Sell
40
Dynatrace (DT)
is a Sell
Is Dynatrace a Buy, Sell or Hold?
-
DT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DT Stock Price Chart
PCVX Stock Price Chart
DT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 11.96 | Buy |
Relative Strength Index (14 RSI): | 24.15 | Sell |
Chaikin Money Flow: | -3625849 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (46.79 - 53.51) | Sell |
Bollinger Bands (100): | (50.38 - 58.54) | Sell |
PCVX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -11.62 | Sell |
Relative Strength Index (14 RSI): | 17.1 | Sell |
Chaikin Money Flow: | 588768 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (48.86 - 80.84) | Sell |
Bollinger Bands (100): | (68.44 - 96.04) | Sell |
DT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 47.37 | Sell |
20-day SMA: | 48.79 | Sell |
50-day SMA: | 54.65 | Sell |
200-day SMA: | 51.66 | Sell |
8-day EMA: | 44.26 | Sell |
20-day EMA: | 33.3 | Buy |
50-day EMA: | 18.33 | Buy |
200-day EMA: | 5.46 | Buy |
PCVX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 46.83 | Sell |
20-day SMA: | 62.86 | Sell |
50-day SMA: | 75.23 | Sell |
200-day SMA: | 88 | Sell |
8-day EMA: | 43.66 | Sell |
20-day EMA: | 57.73 | Sell |
50-day EMA: | 70.53 | Sell |
200-day EMA: | 81.17 | Sell |
Dynatrace Earnings Growth & DT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.20 per share, and an increase next year of $0.17 per share.
Vaxcyte Earnings Growth & PCVX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.36 per share, and a decrease next year of $0.37 per share.
Dynatrace Technical Analysis
Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Vaxcyte Technical Analysis
Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |